Refereed journal article or data article (A1)
Quality of life in treated patients with acromegaly
List of Authors: Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH
Publisher: ENDOCRINE SOC
Publication year: 2006
Journal: Journal of Clinical Endocrinology and Metabolism
Journal name in source: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Journal acronym: J CLIN ENDOCR METAB
Volume number: 91
Issue number: 10
Number of pages: 6
ISSN: 0021-972X
DOI: http://dx.doi.org/10.1210/jc.2006-0676
Abstract
Conclusions: HRQoL is reduced in treated patients with acromegaly. The best HRQoL may be achieved by normalization of IGF-I and by targeting the GHOGTT nadir to levels between 0.3 and 1.0 mu g/liter. Radiotherapy is associated with adverse HRQoL.
Conclusions: HRQoL is reduced in treated patients with acromegaly. The best HRQoL may be achieved by normalization of IGF-I and by targeting the GHOGTT nadir to levels between 0.3 and 1.0 mu g/liter. Radiotherapy is associated with adverse HRQoL.
UTU Research Portal